Comparison of the SARS-CoV-2 spike protein ELISA and the Abbott Architect SARS-CoV-2 IgG nucleocapsid protein assays for detection of antibodies

Serologic assays developed for SARS-CoV-2 detect different antibody subtypes and are based on different target antigens. Comparison of the performance of a SARS-CoV-2 Spike-Protein ELISA and the nucleocapsid-based Abbott Architect(TM) SARS-CoV-2 IgG assay indicated that the assays had high concordan...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2021-07, Vol.16 (7), p.e0255208-e0255208, Article 0255208
Hauptverfasser: Wadhwa, Ashutosh, Yin, Sherry, Freeman, Brandi, Hershow, Rebecca B., Killerby, Marie, Yousaf, Anna R., Lester, Sandra, Mills, Lisa, Buono, Sean A., Pomeroy, Mary, Owusu, Daniel, Chu, Victoria T., Tate, Jacqueline E., Bhattacharyya, Sanjib, Hall, Patricia, Thornburg, Natalie J., Kirking, Hannah L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Serologic assays developed for SARS-CoV-2 detect different antibody subtypes and are based on different target antigens. Comparison of the performance of a SARS-CoV-2 Spike-Protein ELISA and the nucleocapsid-based Abbott Architect(TM) SARS-CoV-2 IgG assay indicated that the assays had high concordance, with rare paired discordant tests results.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0255208